Paycer
Search…
⌃K
Links

Tokenomics

On this page you can learn more about the Paycer PCR tokenomics. PCR is a utility token based on the ERC20 standard launched on the Polygon blockchain. Please find all the important information below.
Paycer Token PCR allocation

1. Paycer Token (PCR)

KEY DATA
Ticker
PCR
Type
ERC20 (on Polygon)
Use Case
Utility Token
Maximum Supply
750M (750,000,000 PCR)
TGE Supply
4.5M PCR
Private Sale
7%
Pre-Sale
4%
Public Sale
5%
Team
10%
Utilities
Voting Right, Staking, Liquidity Mining, Loyalty Tiers, earn more Interests, reduced Fees, earn more Rewards, Token Buyback, Referral Program Bonus
Vesting
Yes
Most of the PCR tokens are allocated to the community and will be distributed by token sales, marketing events, staking rewards and liquidity mining.

2. Private Sale

  • Tokens available for sale: 52,500,000 PCR
  • Token price: $0.025
  • Vesting period: 12 months with a daily release of 1/365 of bought PCR
  • Hardcap: $1,312,500.00

3. Pre-Sale

  • Tokens available for sale: 30,000,000 PCR
  • Token price: $0.045
  • Vesting period: 12 months with a daily release of 1/365 of bought PCR
  • Hardcap: $1,350,000.00

4. Public Sale

  • Tokens available for sale: 37,500,000 PCR
  • Token price: $0.055
  • Vesting period: 6 months with a monthly release of 1/6 of bought PCR
  • Hardcap: $2,062,500.00

5. Team Token

  • Total team tokens: 75,000,000 PCR (10%)
  • Each team member gets an allocation of 750,000 PCR.
  • Vesting period of 36 months with a daily release of 1/1000 of allocated PCR.
  • The remaining PCR tokens remain in the team pool for new team members and as team reserve.

6. Advisor and Partner Tokens

  • Total advisor and partner tokens: 22,500,000 PCR
  • Most tokens will be locked for future partners and advisors.
  • Vesting period: 12 months with a daily release of 1/365 of bought PCR

7. Expected Development of the Circulating PCR Supply

The expected circulating supply will be around 580M PCR 8 years after the TGE. One year after the TGE when most vesting periods are over, the main drivers for the token release will be PCR staking and liquidity mining. Detailed calculations and formulas regarding the token distribution can be found in the Paycer whitepaper.
Expected circulating PCR supply over a period of 96 months.

8. Token Utilities

  1. 1.
    Voting: Participate in votings to influence the development of new features and the roadmap of the Paycer Platform.
  2. 2.
    Staking: Stake PCR to receive staking rewards of up to 24% APY.
  3. 3.
    Loyalty Tiers: Four different loyalty tiers available: Associate, Senior, Manager and Partner. Each loyalty tier comes with an additional bonus for staking rewards, interest rate and fee reduction.
  4. 4.
    More interests: You can add up to +4.5% to your interest rate.
  5. 5.
    Reduced fees: You can reduce your fees for loans up to -20%.
  6. 6.
    More rewards: You can increase your reward rate up to a double.
  7. 7.
    Token buyback: Paycer plans to use a part of its future revenue to buy back PCR tokens. This may require a license or permit that Paycer must obtain.
  8. 8.
    Referral Bonus: The bonus of Paycer's future referral program will also be based on the loyalty tiers. The more tokens you hold the more referral bonus you can receive.

9. Use of Funding

The capital collected from private sale, pre-sale, and public sale will be used for the further development of the Paycer company and all related operations. The largest part of the investment will be allocated to technical development, including the Paycer protocol and platform. Another important point will be marketing and all related activities to reach end customers. Legal and regulatory aspects are also crucial, for instance obtaining a banking license. Continuous business development and exploration of new business areas are also essential. The last major item is operations; this includes infrastructure costs, rent, office equipment, and salaries that do not relate to any of the previously mentioned areas. The precise allocation of the funds is displayed in the following figure.
How the funding will be allocated by Paycer